Lena Hagman
Geschäftsführer bei XVIVO PERFUSION AB
Vermögen: 69 060 $ am 30.04.2024
Aktive Positionen von Lena Hagman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XVIVO PERFUSION AB | Geschäftsführer | 01.12.2022 | - |
Karriereverlauf von Lena Hagman
Ehemalige bekannte Positionen von Lena Hagman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GETINGE AB | Compliance Officer | 01.01.2010 | 01.10.2020 |
| General Counsel | 01.01.2010 | 06.10.2022 | |
Neoventa Medical AB
 Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Geschäftsführer | - | - |
Ausbildung von Lena Hagman
| Chalmers University of Technology | Undergraduate Degree |
Statistik
International
| Schweden | 5 |
Operativ
| Chief Operating Officer | 2 |
| Compliance Officer | 1 |
| General Counsel | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GETINGE AB | Health Technology |
| XVIVO PERFUSION AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Neoventa Medical AB develops and markets monitoring and management tools for neonatal healthcare. Its products include Stan S31, Stan Viewer Live, Stan Viewer, Stan Method, and Goldtrace. The company was founded in 1997 and is headquartered in Mölndal, Sweden. | Health Technology |
- Börse
- Insiders
- Lena Hagman
- Erfahrung
